Brief: Royalty Pharma Highlights Accomplishments And Provides Business Update
Jan 8 (Reuters) - Royalty Pharma RPRX.O :
* HIGHLIGHTS ACCOMPLISHMENTS AND PROVIDES BUSINESS UPDATE AT
42ND
ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
* SAYS 2023 PORTFOLIO RECEIPTS EXPECTED TO BE APPROXIMATELY
$3,050
MILLION, EXCEEDING UPPER END OF GUIDANCE RANGE
* ANNOUNCED TRANSACTIONS OF $13 BILLION SINCE 2020 EXPECTED
TO ADD
APPROXIMATELY $1.2 BILLION TO PORTFOLIO RECEIPTS IN 2025
Source text for Eikon: ID:nGNX1MNxRr
Further company coverage: RPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Royalty Pharma
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
U.S. STOCKS ON THE MOVE-Best Buy, Peloton, Apple
Royalty Pharma falls after Novartis' cholesterol drug fails in study
Brief: Royalty Pharma Announces Update On Novartis’ Phase 3 Topline Results For Pelacarsen
Teva's immune disorder drug meets main goal in mid-stage trial (updated)